IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced that the company intends to ...
Stockholders to also receive two contingent value rights valued at $1 per share, each entitled to be received upon the achievement of certain ...
Executive Chairman of the Board, Fu Wei, informed the Company of his intent to purchase up to $5,000,000 of the Company’s ...
In April, the US Food & Drug Administration (FDA) announced its decision to phase out animal testing requirements for ...
Women who received Elenagen plus chemotherapy lived significantly longer than those who received chemotherapy alone.
The financing includes new investors Pfizer Ventures and Apricot Capital, bringing the total capital raised to $100m ...
RENSSELAER, N.Y. & ARCHAMPS, France--(BUSINESS WIRE)--#acquisition--Taconic Biosciences, Inc., a global leader in genetically engineered rodent models (GEMs) and humanized immune system (HIS) mouse ...
Stockholders to also receive two contingent value rights valued at $1 per share, each entitled to be received upon the achievement of certain milestones Offer represents an approximate 85% premium ove ...
VoxCell appoints Chief Commercial Officer as Demand Grows for Predictive, Human-Relevant, Non-Clinical Testing ...
Rakuten Medical, Inc., a global biotechnology company developing and commercializing Alluminox® platform-based photoimmunotherapy, today announced that it will provide IRDye® 700DX N-hydroxy ...
The Chairman of the Presidential Committee on Fiscal Policy and Tax Reforms, Taiwo Oyedele, has said that he can die ...
Europe’s struggle to produce globally dominant companies is not a mystery—it is the predictable result of a weak and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback